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Objective: To analyse the development of the medical and surgical treatment of acute
diverticulitis to develop an appropriate decision-making algorithm.
Methods: We analysed the demographic characteristics, radiological images, disease
severity, treatments and surgical outcomes of all of the patients with a diagnosis of acute
diverticulitis admitted to the Department of General and Emergency Surgery between 1
January 2009 and 30 June 2014.
Results: During the 66-month study period, 219 patients with acute diverticulitis
attended our department; 69% had simple diverticulitis (93% were treated conservatively
and 7% surgically) and 31% had complicated diverticulitis (76% were treated surgically
and 24% conservatively). Of the patients who were treated surgically, 62.5% underwent
primary resection with anastomosis, 31.94% Hartmann's procedure, and 5.56% laparo-
scopic lavage and drainage.
Conclusions: Our cases and a careful review of the literature allowed us to develop a
decision-making algorithm for patients with acute diverticulitis.1. Introduction
Diverticulitis is the most frequent surgically treated disease
after cancer in modern Western societies, and its incidence is
increasing with the older average age of the population. It affects
10% of the people living in industrialised countries: 5% aged
<40 years, 30% aged >60 years and 65% aged >80 years[1].
Only 16% of patients experience a ﬁrst episode at an age
<45 years while the average age of hospitalization for the ﬁrst
episode of acute diverticulitis is 63 years[2,3].
Diverticulitis is a heterogeneous disease that 75% of cases
occur in uncomplicated form while 25% of cases can be
complicated by abscess, ﬁstula, peritonitis, obstruction and
haemorrhage[4].
Disease severity is classiﬁed using Hinchey's staging system[5],
as modiﬁed by Wasvary et al. in 1999: Stage 0 mild clinical
diverticulitis; Stage IA conﬁned pericolic inﬂammation or
phlegmon; Stage IB pericolic or mesocolic abscess; Stage II
pelvic, distant intra-abdominal or retroperitoneal abscess; StageIII generalised purulent peritonitis; and Stage IV generalised faecal
peritonitis (Table 1)[6]. Treatment mainly depends on disease
severity and recent surgical strategies have concentrated on
reducing the duration of surgery and postoperative complications[7].
The ﬁrst surgical technique, known as the “three-stage pro-
cedure”, was developed by Mayo et al. in 1907: a colostomy at
the level of the transverse colon and the positioning of drainage;
the resection of the diseased colon after a period of 3–6 months;
and stoma closure after a further 3–6 months[8]. The morbidity
rate was acceptable, but it was burdened by a high rate of
mortality (30%–60%) because the diseased colon remained in
situ for a long time and was a signiﬁcant source of infection[9].
The second method, the “two-stage” or Hartmann's proce-
dure (HP), was used for the ﬁrst time by Henry Hartmann in
1921 in order to perform sigmoid resection for the treatment of
neoplastic disease[10]. It consists of a segmental resection of the
diseased colon without a primary anastomosis but with an end
colostomy[11]; intestinal continuity can be restored during a
second operation, but this is not possible in 20%–50% of
cases[12]. Widely used since the 1950s, HP became the
standard of care in the 1980s, but has a signiﬁcant
complication rate and mortality rates range from 5% to 14%[13].
A “one-stage” procedure [primary resection with anastomosis
(PRA)] has been proposed since 1990. The most feared
Table 1
Hinchey staging system as modiﬁed by Wasvary and CT ﬁndings according to Ambrosetti's criteria.
Hinchey classiﬁcation modiﬁed by Wasvary CT ﬁndings (Ambrosetti's criteria)
Stage 0 Mild clinical diverticulitis Diverticula with or without colonic wall thickening
Stage IA Conﬁned pericolic inﬂammation or phlegmon Colonic wall thickening and inﬂammatory reaction of pericolic fatty tissue
Stage IB Pericolic or mesocolic abscess Colonic wall thickening, inﬂammatory reaction of pericolic fatty tissue and
pericolic or mesocolic abscess
Stage II Pelvic, distant intra-abdominal or retroperitoneal
abscess
Colonic wall thickening, inﬂammatory reaction of pericolic fatty tissue and
pelvic/distant intra-abdominal/retroperitoneal abscess
Stage III Generalised purulent peritonitis Extraluminal air/extraluminal contrast
Stage IV Generalised faecal peritonitis Extraluminal air/extraluminal contrast
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occurs in 6% of cases, particularly when there is considerable
peritoneal contamination; however, the risk of anastomotic
dehiscence can be reduced by performing a proximal loop
ileostomy to be closed during a second procedure[14].
In a bid to reduce the mortality and morbidity associated with
emergency surgery, a new approach that consists of adminis-
tering intravenous antibiotics and performing a percutaneous
drainage (PCD) of major abscesses or using laparoscopic lavage
of the abdominal cavity with the positioning of drainages
[laparoscopic lavage and drainage (LLD)] has recently been
adopted.
It has been noted that mortality is very low in patients treated
in this manner, who are discharged earlier than those undergoing
HP[15]. PCD can be performed under ultrasound (US) or
computed tomography (CT) guidance, and drainage is usually
done through the anterior or lateral abdominal wall in order to
avoid damaging the inferior epigastric artery and deep
circumﬂex iliac vessels, although transgluteal, transperineal,
transvaginal and transanal approaches can also be used[16].
Complications, such as bleeding, visceral perforation, solid
organ injury and ﬁstulation only occur in 5% of cases, and the
failure rate ranges from 15% to 30%[17].
LLD is a minimally invasive operation that consists of
aspirating free purulent ﬂuid from the peritoneal cavity, mobi-
lising inﬂammatory abdominal wall attachments from the
inﬂamed colon, opening purulent cavities and copious (>4 L)
washings with a warmed iodine and saline solution, followed by
the placement of drainages. This operation is supported by the
administration of intravenous antibiotics. The use of LLD to
manage severe diverticulitis with generalised peritonitis is
associated with mortality and morbidity rates less than 5%, and
so it is useful in patients with Hinchey stage III or IV
diverticulitis[18].
Finally, Damage Control Surgery (DCS) is an approach that
can be used for patients with peritonitis caused by acute perfo-
rated diverticulitis who are rapidly developing septic shock. The
technique was created in 1983 by Stone et al. as a means of
treating trauma patients presenting with the bloody viscous cy-
cle: acidosis, hypothermia, coagulopathy[19], but can also be used
for patients with intra-abdominal sepsis that may rapidly evolve
in septic shock as they are too unstable to undergo immediate
surgery and have an high postoperative risk of acute kidney
injury and multiple organ failure[20]. In the case of acute
diverticulitis with perforation and severe septic shock, DCS
consists of a limited resection of the inﬂamed perforated colon
using staplers without making a colostomy, after which the
abdominal wall is temporarily closed using the vacuum-
assisted closure (VAC) technique. The patients are thentransferred to an ICU for ongoing resuscitation and, once their
physiological status has been optimised, returned to the oper-
ating room to undergo peritoneal lavage and colostomy or pri-
mary anastomosis depending on the condition of the bowel
(oedema and hypoperfusion of the wall), their comorbidities and
the surgeon's experience[21].
Given the frequency and severity of the disease, and the
rapidly evolving therapeutic scenario, the aim of this study was
to analyse the development of the medical and surgical treatment
of acute diverticulitis on the basis of a literature review and our
own clinical experience in order to develop an appropriate
decision-making algorithm.
2. Materials and methods
We considered all of the patients admitted to the Department
of General and Emergency Surgery, IRCCS Ca’ Granda –
Maggiore Policlinico Hospital Foundation (Milan, Italy) be-
tween 1 January 2009 and 30 June 2014 with a diagnosis of
acute diverticulitis. Diverticulitis was diagnosed by evaluating
the patients’ history, clinical features (left lower abdominal pain,
tenderness, palpable resistance, fever, diarrhoea, constipation,
vomiting, and urinary disorders), laboratory ﬁndings (leuko-
cytes, C-reactive protein, s-amylase, s-lipase, s-aminotrans-
ferase, s-alkaline phosphatase, s-bilirubin, s-electrolytes),
abdominal radiography and CT scan in order to conﬁrm the
suspected diagnosis by excluding other causes of abdominal
pain and allow disease staging. We also analysed their de-
mographic characteristics, disease severity and treatments, and
ﬁnally examined their surgical outcomes on the basis of oper-
ating times, the number of days of analgesia, the resumption of
peristalsis and canalisation, the day of nasogastric tube (NGT)
removal, the resumption of eating, the duration of hospital-
isation, the incidence of major and minor complications, reop-
erations, and intra- or postoperative mortality.
3. Results
During the 66-month study period, 219 patients with acute
diverticulitis [47% males and 53% females; mean age 61.9 years
(range 25–94); median age 63 years] attended the Department of
General and Emergency Surgery; 10% aged <40 years, 33%
aged 40–60 years, 42% aged 60–80 years, and 15% aged
>80 years (fully in line with the age distribution described in the
literature)[22]. The age- and gender-related disease prevalence
rates was also the same as those previously published[23]: the
disease was more prevalent among males than females aged
<50 years (74% vs. 26%; M:F = 2.9:1); similarly prevalent
among those aged 50–70 years (52% vs. 48%; M:F = 1.1:1);
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(21% vs. 79%; M:F = 0.28:1). Males therefore developed the
disease at a younger age, but overall gender frequency was
similar (47% vs. 53%; M:F = 0.8:1).
The disease was mainly localised at the level of the
descending colon and/or sigma (89%), and less frequently at the
level of the caecum, and the ascending and transverse colon
(11%). Caecal and ascending colon diverticula are generally
congenital[24], and attacks of acute diverticulitis in these regions
occur earlier, at a median age of 49 years.
In line with the ﬁndings of previous studies (75% and
25%)[25], diverticulitis was simple (Hinchey Stage 0, IA or IB) in
69% of the patients, and Hinchey Stage II, III or IV, or
complicated by stenosis or ﬁstulas in 31%.
The vast majority (93%) of the patients with uncomplicated
diverticulitis were treated conservatively, and only 7% under-
went surgery, whereas 76% of the patients with complicated
diverticulitis were treated surgically and 24% were treated
conservatively. These ﬁgures are slightly different from other
published data, which indicate that 85% of patients with un-
complicated diverticulitis can be treated conservatively, with
negligible mortality and success rates of 70%–100% (the
remaining 15% generally do not respond to conservative treat-
ment)[26], and that surgery is required in 90%–95% of patients
with complicated diverticulitis, with only 5%–10% responding
to conservative treatment (Figure 1)[27].
Our patients in Hinchey Stage 0, IA, IB, and Stage II with
abscesses of <3 cm were usually treated conservatively, which
involved: complete bowel rest and start of parenteral feeding; the
placement of NGT in case of nausea and vomiting or abdominal
distension; intravenous antibiotics: ciproﬂoxacin 400 mg twice a
day and metronidazole 500 mg three times daily.
Once the clinical symptoms have improved and inﬂammatory
indices have decreased, enteral feeding is started and antibiotic
therapy is administered orally: ciproﬂoxacin 500 mg twice a day
and metronidazole 500 mg three times daily. When the symp-
toms have completely remitted, the patient is discharged and
continues antibiotic therapy at home until the end of the 14-day
cycle; we also recommend a ﬁbre-free diet for about 20 days,
after which ﬁbre can be gradually reintroduced. Finally, givenFigure 1. Management of patients with acute diverticulitis: our experience
and a summary of previously published experiences.the likelihood of disease exacerbation, the patients are advised to
return for a check-up 4–6 weeks after discharge in order to
assess the need for surgical resection.
During the study period, average hospitalisation was 4.68
days: 76% of the patients stayed in hospital for up to 5 days,
21% for 2–10 days, and only 3% for >10 days. Treatment was
successful in 100% of cases.
The patients in Hinchey Stage II with abscesses of >3 cm
were treated with conservatively as described above, with the
addition of the US-guided placement of PCD through the ante-
rior abdominal wall (86%) or trans-vaginally (14%). The cath-
eter was left in place for an average of eight days (range 1–19
days) until the drained material was <10 mL/24 hours and the
indices of inﬂammation had decreased. The average recovery
time was nine days (range 6–21 days) and there were not
complications related to the procedure. All of the patients were
discharged with an indication to return for a check-up in order to
assess the need for surgical resection.
The diverticulitis was uncomplicated in 19.44% of the sur-
gically treated patients, who underwent surgery after an average
of six days of antibiotic therapy. Surgery was considered
necessary because of the risk of a sudden clinical and/or the
possibility of recurrence.
Complicated diverticulitis was observed in 80.56% of the
patients: 25% in Hinchey Stage II, 33.33% in Hinchey Stage III,
13.89% in Hinchey Stage IV, 4.17% with occlusions, and 4.17%
with ﬁstulae.Surgical treatment consisted of PRA in 62.5% of
the patients (17.78% with and 82.22% without loop ileostomy),
HP in 3.94%, LLD in 5.56%.
PRA was mainly used in patients with uncomplicated acute
diverticulitis (31.11%), and in those in Hinchey Stage II
(28.89%) and III (22.22%), and less frequently in those in
Hinchey Stage IV (4.44%) and those with diverticulitis
complicated by occlusions (6.67%) or ﬁstulae (6.67%), and HP
was mainly used in patients in Hinchey Stage III (56.52%) and
IV (34.78%), and less frequently in those in Hinchey Stage II
(8.7%). LLD was used in patients in Hinchey Stage II (75%) and
III (25%).
Outcomes were better in the patients who underwent PRA
than in those undergoing HP: less postoperative pain (5.98 vs.
12.25 days of analgesic therapy), more rapid resumption of
peristalsis (2.44 vs. 3.25 days) and canalisation (5.31 vs. 6.25
days), earlier NGT removal (3.71 vs. 5 days), more rapid
resumption of eating (5.16 vs. 6.70 days), a shorter hospital stay
(15.11 vs. 19.70 days), lower rate of minor complications
(47.7% vs. 59.1%) and major complications (23.82% vs. 36.4%),
less frequent reoperations (14% vs. 18%) and a lower mortality
rate (0% vs. 13.6%). The most feared complication of PRA
(anastomosis leakage) occurred in only 2.98% of cases. Finally,
it was possible to close the ileostomy in 100% of the PRA pa-
tients, whereas intestinal continuity was restored only in 41% of
those who underwent HP.
In Table 2, LLD also led to better outcomes than HP in terms
of the need for analgesic therapy (7.75 vs. 12.25 days).
The resumption of peristalsis was the same (3.25 days), but
canalisation took longer (8.00 vs. 6.25 days) and so the
resumption of eating was later (7.00 vs. 6.70 days). There
weren't minor (0% vs. 59.1%) or major complication (0% vs.
36.4%), reoperation wasn't necessary (0% vs. 18%) and the
mortality rate was 0% vs. 13.6%. Furthermore, operating time
was shorter (94 vs. 201 min), a very important advantage in
the case of patients at high operatory risk, and the patients
Table 2
Outcomes of surgical patients.
Outcomes LLD (n = 4) PRA (n = 45) HP (n = 23)
Operating time (min) 94.00 (54–149) 256.20 (90–1964) 201.43 (130–329)
Days of analgesia 7.75 (3–18) 5.98 (2–28) 12.25 (3–65)
Resumption of peristalsis 3.25 (1–9) 2.44 (1–23) 3.25 (1–13)
Resumption of canalisation 8.00 (4–13) 5.31 (2–25) 6.25 (3–17)
Day NGT removed 4.00 (1–9) 3.71 (1–25) 5.00 (2–13)
Resumption of eating 7.00 (3–15) 5.16 (2–28) 6.70 (3–19)
Length of hospital stay (days) 14.50 (7–29) 15.11 (6–58) 19.70 (7–87)
Major complications 0% 23.82% 36.4%
Minor complications 0% 47.70% 59.1%
Re-operations 0% 14.00% 18.0%
Mortality rate 0% 0.00% 13.6%
Bowel continuity reconstruction 100% 100.00% 41.0%
Figure 2. Decision making algorithm for patient with acute diverticulitis.
Sibilla Focchi et al./Journal of Acute Disease 2015; 4(4): 280–286 283
Sibilla Focchi et al./Journal of Acute Disease 2015; 4(4): 280–286284enjoyed the beneﬁts of undergoing a minimally invasive
technique, and the fact that any resection necessary could be
performed minimally invasively during a quiescent stage of
disease, thus reducing the risks involved in emergency surgery
(Table 2).
Analysis of our and other published experiences allowed us
to establish a decision-making algorithm for patients with acute
diverticulitis (Figure 2).
4. Discussion
Our experience shows that a decision-making algorithm is
very useful to establish the correct treatment for patient with
acute diverticulitis. After disease diagnosis and staging using
Wasvary's revised version of the Hinchey staging system, it is
possible to proceed as follow below.
4.1. Hinchey Stage III/IV with septic shock
In the case of patients in Hinchey Stage III or IV, it is
necessary to determine whether there are any signs of septic
shock: hypothermia (body temperature <36 C) or fever (body
temperature >38 C); heart rate >90/min; leucocytosis (white
blood cells >12000/mL) or leukopenia (white blood cells
<4000/mL); tachypnea (respiratory rate >20 breaths/min) or
PaCO2 <4 kPa.
In the presence of signs of septic shock, preoperative opti-
misation is necessary. This takes 2–3 h and involves: the
placement of two large-bore intravenous lines for the infusion of
broad-spectrum antibiotics and a bolus of isotonic crystalloid
(20 mL/kg); the US-guided establishment of a central line via the
internal jugular for the administration of ﬂuids until central
venous pressure is between 8 and 12 mmHg; the placement of an
arterial line; tracheal intubation and mechanical ventilation
(target tidal volume 6 mL/kg); the administration of norepi-
nephrine in order to maintain a mean arterial pressure of
>65 mmHg; the correction of electrolyte abnormalities; the
infusion of blood cells if haematocrit is <30%[28].
After preoperative optimisation, the patient should be re-
evaluated and, if still in septic shock, should undergo DCS
which consists of abdominal cavity lavage, limited bowel
resection of the inﬂamed perforated colon using staplers, without
colostomy or anastomoses, temporary abdominal vacuum-
assisted closure. The patient is then returned to the ICU for
treatment to improve vital parameters and allow the second and
ﬁnal operation after 24–48 h.
Reconstructive surgery may consist of abdominal cavity
lavage and colostomy. According to Kafka-Ritsch et al.[29] and
Perathoner et al.[30], after evaluating the condition of the colon
(oedema and perfusion) and the patient's comorbidities, bowel
continuity can be restored with or without a loop ileostomy.
DCS allows sepsis to be controlled by resecting the perfo-
rated bowel tract: by avoiding the dissection of tissues and or-
gans, this reduces the risk of propagating the inﬂammatory
process and spreading toxaemia. The stapled resection limited to
the diseased bowel and the dead-end maintenance of the stumps
also limits the spread of inﬂammation and contamination of the
retroperitoneal space. Another advantage of DCS is that it allows
the restoration of intestinal continuity using a primary anasto-
mosis in patients who, without DCS, would undergo HP because
of the severity of the disease, inﬂammation of the bowel tract,
and contamination.4.2. Hinchey Stage III/IV without septic shock
In the case of patients in Hinchey Stage III or IV without any
signs of septic shock, or in whom preoperative optimisation has
resolved previous septic shock, it is possible to select: Hart-
mann's procedure; primary resection with anastomosis; laparo-
scopic lavage and drainage. The choice of the most appropriate
technique depends on: the severity of the disease; the condition
of the intestine to anastomose (inﬂammation, vascularisation);
the patient's clinical condition (nutritional status, comorbidities);
the experience of the surgical team.
HP was long considered the gold standard for perforated
diverticulitis with peritonitis, and is still used even though it
leads to high mortality and morbidity rates, and bowel continuity
cannot be restored in 20%–50% of patients because of the
serious operative risks. However, its still frequent use is justiﬁed
by the fact that removing the diseased colon and avoiding the
anastomosis of the infected and inﬂamed colonic tract reduce the
risk of anastomotic leakage; furthermore, it is still a good choice
for unstable patients and the elderly with serious comorbidities
insofar as it reduces the duration of surgery and peritoneal
contamination.
The PRA is preferred to HP in selected cases because: it
reduces mortality rate; it is associated with fewer postoperative
complications; it decreases the duration of hospitalisation; it
avoids the need for a second operation in order to restore in-
testinal continuity, which involves many operative risks[31].
The most serious complication of PRA is anastomotic
leakage due to the suture being made on an insufﬁciently pre-
pared, inﬂamed and infected colon. In an emergency, the prep-
aration of the bowel can be replaced by colon lavage on the
operating table, which reduces the risk of infection and faecal
load on the anastomosed intestinal tracts[32,33]. A loop ileostomy
is an important means of decreasing the risk of anastomotic
leakage[34,35].
LLD has been developed in an attempt to reduce HP-related
mortality and morbidity. It involves an abdominal cavity lavage
and the laparoscopic placement of drainages in addition to the
administration of intravenous antibiotics.
The advantages of LLD are: it reduces the risk of colon
resection in an acute situation; it reduces painful symptoms; it
avoids a stoma; it rapidly improves the patient's clinical condi-
tion and reduces the duration of hospitalisation; elective colon
resection using a minimally invasive procedure reduces the
mortality and morbidity (infection and wound dehiscence,
anastomosis dehiscence, post-incisional hernia) associated with
emergency surgery[18,36].
LLD is an effective and safe means of treating Stage III
diverticulitis[37,38], with an efﬁcacy rate of 95.7%, a morbidity
rate of 10.4%, and a mortality rate of 1.7%[39].
Moreover, associated with laparoscopic sigmoid closure, it
can also used in patients in Stage IV. The sigmoid perforation
can be closed using Lambert's technique and discontinuously
delayed absorbance sutures, and further buttressed using Gra-
ham's patch-like technique and a piece of epiploic appendix[40].
4.3. Hinchey Stage IB and II
Patients in Hinchey Stage IB and II can be treated in two
different ways: 1) in the case of abscesses <3 cm with no evi-
dence of pneumoperitoneum, they should be treated using con-
servative medical therapy: complete bowel rest and the start of
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nausea and vomiting, or abdominal distension; the administra-
tion of intravenous antibiotics providing empiric coverage
against Gram-negative and aerobic pathogens. The ﬁrst-choice
antibiotics are: ampicillin–sulbactam (3 g four times daily i.v.),
piperacillin–tazobactam (3.375 or 4.5 g four times daily i.v.),
ticarcillin–clavulanate (3.1 g four times daily i.v.), ceftriaxone
(1 g once daily i.v.) plus metronidazole (500 mg three times
daily i.v.). The second-choice antibiotics are: ciproﬂoxacin
(400 mg twice daily i.v.) plus metronidazole (500 mg three times
daily i.v.), levoﬂoxacin (500 or 750 mg once daily i.v.) plus
metronidazole (500 mg three times daily i.v.), imipenem–cil-
astatin (500 mg four times daily i.v.), meropenem (1 g three
times daily i.v.), doripenem (500 mg three times daily i.v.), and
ertapenem (1 g once daily i.v.). Antibiotic doses should be
appropriately adjusted for patients with renal insufﬁciency or
other dose-related problems[41]. 2) in case of abscess of >3 cm,
they should be treated using the conservative medical therapy
described and the positioning of PCD.
PCD can be positioned under US or CT guidance through the
anterior or lateral abdominal wall, or transgluteally, trans-
perineally, transvaginally or transanally.
The catheter is left in place until the drained material is
<10 mL/24 h, but not for more than 30 days. The patients’
clinical condition generally improves after 24–48 h, but emer-
gency surgery is necessary if it worsens[42]. PCD has a failure
rate between 15% and 30%, and the rate of recurrence is
40%[43], and higher in the case of abscesses of >5 cm[44].
The advantages of PCD are: it allows the conservative
treatment of sepsis; it reduces the risk of emergency surgery by
favouring elective resection with primary colorectal
anastomosis[45].
4.4. Hinchey Stage 0 and IA
Patients in Hinchey Stage 0 and IA experience an uncom-
plicated attack of acute diverticulitis, and can be treated as in-
patients or outpatients.
Patients with uncomplicated diverticulitis can be treated in an
outpatient setting if: they can be relied on to return for a medical
re-evaluation if the condition worsens; they comply with an
outpatient treatment plan; the abdominal pain is not severe; they
have low-grade fever (<38 C/100.4 F); they can tolerate of
oral intake; they have minimal comorbidities. Elderly and
immunosuppressed patients should generally be hospitalised.
Outpatient treatment involves: the consumption of only clear
liquids until a clinical improvement is clear (usually two or three
days), after which the diet can be slowly normalised; the
administration of oral antibiotics against Gram-negative rods
and anaerobes (particularly Escherichia coli and Bacteroides
fragilis) for 7–14 days; bed rest. The ﬁrst-choice antibiotics are:
ciproﬂoxacin (500 mg twice daily p.o.) plus metronidazole
(500 mg three times daily p.o.), amoxicillin–clavulanate (875/
125 mg twice daily p.o.), sulfamethoxazole–trimethoprim (800/
160 mg twice daily p.o.) plus metronidazole (500 mg three times
daily p.o.). For patients intolerant to metronidazole, clindamycin
(400 mg three times daily p.o.) or moxiﬂoxacin (400 mg once
daily p.o.) may be an acceptable alternative. Antibiotic doses
should be appropriately adjusted for patients with renal insufﬁ-
ciency or other dose-related problems[46].
Outpatients should be advised to return to hospital if they feel
increasing pain and fever and/or develop intolerance to ﬂuids.In-patients should undergo conservative therapy, including:
the consumption of only clear liquids, or complete bowel rest
and the start parenteral feeding if oral feeding is not tolerated;
the placement of an NGT in the case of nausea and vomiting, or
abdominal distension; the administration of intravenous antibi-
otics providing empiric coverage against Gram-negative and
aerobic pathogens.
Intravenous antibiotics should be administered until the
inﬂammation has stabilised, and pain and tenderness are
decreasing (typically 3–5 days after starting treatment), after
which the patient can be switched to oral antibiotics in order to
complete 10–14 days of antibiotic therapy. The ﬁrst-choice an-
tibiotics are: ciproﬂoxacin (400 mg twice daily i.v. or 500 mg
twice daily p.o.) plus metronidazole (500 mg three times daily
i.v. or 500 mg three times daily p.o.), amoxicillin-clavulanate
(1000/200 mg three times daily i.v. or 875/125 mg twice daily
p.o.), sulfamethoxazole–trimethoprim (750/150 mg four times
daily i.v. or 800/160 mg twice daily p.o.) plus metronidazole
(500 mg three times daily i.v. or 500 mg three times daily p.o.).
For patients intolerant to metronidazole, clindamycin (300 mg
three times daily i.v. or 400 mg three times daily p.o.) or
moxiﬂoxacin (400 mg once daily i.v./p.o.) may be an acceptable
alternative. Antibiotic doses should be appropriately adjusted for
patients with renal insufﬁciency or other dose-related
problems[47,48].
Anticholinergic drugs and antispasmodics can decrease the
pain by decreasing muscle contractions and, in cases of more
persistent pain, meperidine may be used. Morphine is not indi-
cated because it has the effect of increasing colic pressure.
Once the acute phase is over, the patients should be advised
to follow a high-ﬁbre diet because a long-term high-ﬁbre diet
can reduce the incidence of disease recurrences.
Because of the risk of the recurrence of acute diverticulitis,
all patients in Hinchey Stage 0, IA, IB, II and III treated with
PCD or LLD must be followed up, and need to be checked after
4–6 weeks in order to evaluate the need for surgical resection.
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